Eluxadoline for the Treatment of Diarrhea-Predominant Irritable Bowel Syndrome: Results of 2 Randomized, Double-blind, Placebo-Controlled Phase 3 Clinical Trials of Efficacy and Safety

被引：0
|
作者：
Lembo, Anthony
Dove, Scott
Andrae, David
Davenport, J. Michael
McIntyre, Gail
Almenoff, June
Covington, Paul S.
机构：
来源：
GASTROENTEROLOGY | 2014年 / 146卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
929d
引用
收藏
页码：S159 / S159
页数：1
相关论文
共 50 条
  • [1] Eluxadoline for the treatment of irritable bowel syndrome with diarrhea (IBS-D): results of two randomized, double-blind, placebo-controlled Phase 3 clinical trials
    Covington, Paul
    PHARMACOTHERAPY, 2015, 35 (11): : E189 - E189
  • [2] Eluxadoline Demonstrates Sustained Efficacy for the Treatment of Diarrhea-Predominant Irritable Bowel Syndrome in Phase 3 Clinical Trials
    Chey, William D.
    Dove, Scott
    Andrae, David
    Davenport, J. Michael
    Turner, Lisa
    Lopez, Rocio
    Covington, Paul S.
    GASTROENTEROLOGY, 2015, 148 (04) : S70 - S71
  • [3] Efficacy of Chinese Herbal Medicine for Diarrhea-Predominant Irritable Bowel Syndrome: A Meta-Analysis of Randomized, Double-Blind, Placebo-Controlled Trials
    Zhu, Jia-Jie
    Liu, Shan
    Su, Xiao-Lan
    Wang, Zi-Song
    Guo, Yu
    Li, Yi-Jie
    Yang, Yang
    Hou, Li-Wei
    Wang, Qing-Guo
    Wei, Ru-Han
    Yang, Jian-Qin
    Wei, Wei
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2016, 2016
  • [4] The Effect of Phloroglucinol in Patients With Diarrhea-predominant Irritable Bowel Syndrome: A Randomized, Double-blind, Placebo-controlled Trial
    Shin, Seung Yong
    Cha, Bong Ki
    Kim, Won-Seok
    Park, Jae Yong
    Kim, Jeong Wook
    Choi, Chang Hwan
    JOURNAL OF NEUROGASTROENTEROLOGY AND MOTILITY, 2020, 26 (01) : 117 - 127
  • [5] A randomized, double-blind, placebo-controlled study to assess efficacy of mirtazapine for the treatment of diarrhea predominant irritable bowel syndrome
    Khalilian, Alireza
    Ahmadimoghaddam, Davoud
    Saki, Shiva
    Mohammadi, Younes
    Mehrpooya, Maryam
    BIOPSYCHOSOCIAL MEDICINE, 2021, 15 (01)
  • [6] A randomized, double-blind, placebo-controlled study to assess efficacy of mirtazapine for the treatment of diarrhea predominant irritable bowel syndrome
    Alireza Khalilian
    Davoud Ahmadimoghaddam
    Shiva Saki
    Younes Mohammadi
    Maryam Mehrpooya
    BioPsychoSocial Medicine, 15
  • [7] The Efficacy of Shugan Jianpi Zhixie Therapy for Diarrhea-Predominant Irritable Bowel Syndrome: A Meta-Analysis of Randomized, Double-Blind, Placebo-Controlled Trials
    Xiao, Ya
    Liu, Yanyan
    Huang, Shaohui
    Sun, Xiaomin
    Tang, Yang
    Cheng, Jingru
    Wang, Tian
    Li, Fei
    Kuang, Yuxiang
    Luo, Ren
    Zhao, Xiaoshan
    PLOS ONE, 2015, 10 (04):
  • [8] Modified Gwakjeongtang for Diarrhea-Predominant Irritable Bowel Syndrome: Study Protocol for a Randomized, Double-Blind, Placebo-Controlled, Pilot Clinical Trial
    Choi, Yujin
    Ha, Na-Yeon
    Kim, Ae-Ran
    Jeong, Haein
    Kwon, Ojin
    Park, Ki-Sun
    Kim, Jieun
    Kim, Jinsung
    Kim, Hyungjun
    INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2024, 17 : 1545 - 1556
  • [9] Clinical potential of eluxadoline in the treatment of diarrhea-predominant irritable bowel syndrome
    Sobolewska-Wlodarczyk, Aleksandra
    Wlodarczyk, Marcin
    Storr, Martin
    Fichna, Jakub
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2016, 12 : 771 - 775
  • [10] Gut Microbiota is Not Modified by Randomized, Double-Blind, Placebo-Controlled Trial of VSL#3 in Diarrhea-Predominant Irritable Bowel Syndrome
    Michail, Sonia
    Kenche, Harshavardhan
    PROBIOTICS AND ANTIMICROBIAL PROTEINS, 2011, 3 (01) : 1 - 7
12345